Statistics

Total Visits

Views
Brigatinib Versus Crizotinib in Advanced ALK Inhibitor-Naive ALK-Positive Non-Small Cell Lung Cancer: Second Interim Analysis of the Phase III ALTA-1L Trial21

File Visits

Downloads
36218-371.pdf12

Select a period of time:

Number of views in the range

Views
Brigatinib Versus Crizotinib in Advanced ALK Inhibitor-Naive ALK-Positive Non-Small Cell Lung Cancer: Second Interim Analysis of the Phase III ALTA-1L Trial7

Number of downloads in the range

Downloads
36218-371.pdf6

Views

Views
May 20244
June 20241
July 20240
August 20241
September 20241
October 20240
November 20240
Download CSV file
 untranslated
 untranslated

Number of downloads in the period of time

  • Downloads
  • May 2024
    2
  • June 2024
    3
  • July 2024
    1
  • August 2024
    0
  • September 2024
    0
  • October 2024
    0
  • November 2024
    0
  • Download CSV file
 untranslated
 untranslated

Top country views

Views
United States5
Spain1
 

Top countries by downloads

Downloads
United States6
 

Top cities views

Views
Chicago1
Fort Worth1
Madrid1
 

Top cities by downloads

Downloads